Cargando…

The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets

The coronavirus disease 2019 (COVID-19) pandemic, causing considerable mortality and morbidity worldwide, has fully engaged the biomedical community in attempts to elucidate the pathophysiology of COVID-19 and develop robust therapeutic strategies. To this end, the predominant research focus has bee...

Descripción completa

Detalles Bibliográficos
Autores principales: Hollenberg, Morley D., Epstein, Murray
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931295/
https://www.ncbi.nlm.nih.gov/pubmed/35316977
http://dx.doi.org/10.1016/j.kisu.2021.12.001
_version_ 1784671227011399680
author Hollenberg, Morley D.
Epstein, Murray
author_facet Hollenberg, Morley D.
Epstein, Murray
author_sort Hollenberg, Morley D.
collection PubMed
description The coronavirus disease 2019 (COVID-19) pandemic, causing considerable mortality and morbidity worldwide, has fully engaged the biomedical community in attempts to elucidate the pathophysiology of COVID-19 and develop robust therapeutic strategies. To this end, the predominant research focus has been on the adaptive immune response to COVID-19 infections stimulated by mRNA and protein vaccines and on the duration and persistence of immune protection. In contrast, the role of the innate immune response to the viral challenge has been underrepresented. This overview focuses on the innate immune response to COVID-19 infection, with an emphasis on the roles of extracellular proteases in the tissue microenvironment. Proteinase-mediated signaling caused by enzymes in the extracellular microenvironment occurs upstream of the increased production of inflammatory cytokines that mediate COVID-19 pathology. These enzymes include the coagulation cascade, kinin-generating plasma kallikrein, and the complement system, as well as angiotensin-generating proteinases of the renin–angiotensin system. Furthermore, in the context of several articles in this Supplement elucidating and detailing the trajectory of diverse profibrotic pathways, we extrapolate these insights to explore how fibrosis and profibrotic pathways participate importantly in the pathogenesis of COVID-19. We propose that the lessons garnered from understanding the roles of microenvironment proteinases in triggering the innate immune response to COVID-19 pathology will identify potential therapeutic targets and inform approaches to the clinical management of COVID-19. Furthermore, the information may also provide a template for understanding the determinants of COVID-19–induced tissue fibrosis that may follow resolution of acute infection (so-called “long COVID”), which represents a major new challenge to our healthcare systems.
format Online
Article
Text
id pubmed-8931295
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-89312952022-03-18 The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets Hollenberg, Morley D. Epstein, Murray Kidney Int Suppl (2011) Review The coronavirus disease 2019 (COVID-19) pandemic, causing considerable mortality and morbidity worldwide, has fully engaged the biomedical community in attempts to elucidate the pathophysiology of COVID-19 and develop robust therapeutic strategies. To this end, the predominant research focus has been on the adaptive immune response to COVID-19 infections stimulated by mRNA and protein vaccines and on the duration and persistence of immune protection. In contrast, the role of the innate immune response to the viral challenge has been underrepresented. This overview focuses on the innate immune response to COVID-19 infection, with an emphasis on the roles of extracellular proteases in the tissue microenvironment. Proteinase-mediated signaling caused by enzymes in the extracellular microenvironment occurs upstream of the increased production of inflammatory cytokines that mediate COVID-19 pathology. These enzymes include the coagulation cascade, kinin-generating plasma kallikrein, and the complement system, as well as angiotensin-generating proteinases of the renin–angiotensin system. Furthermore, in the context of several articles in this Supplement elucidating and detailing the trajectory of diverse profibrotic pathways, we extrapolate these insights to explore how fibrosis and profibrotic pathways participate importantly in the pathogenesis of COVID-19. We propose that the lessons garnered from understanding the roles of microenvironment proteinases in triggering the innate immune response to COVID-19 pathology will identify potential therapeutic targets and inform approaches to the clinical management of COVID-19. Furthermore, the information may also provide a template for understanding the determinants of COVID-19–induced tissue fibrosis that may follow resolution of acute infection (so-called “long COVID”), which represents a major new challenge to our healthcare systems. Elsevier 2022-04 2022-03-18 /pmc/articles/PMC8931295/ /pubmed/35316977 http://dx.doi.org/10.1016/j.kisu.2021.12.001 Text en © 2022 International Society of Nephrology. Published by Elsevier Inc. All rights reserved.
spellingShingle Review
Hollenberg, Morley D.
Epstein, Murray
The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title_full The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title_fullStr The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title_full_unstemmed The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title_short The innate immune response, microenvironment proteinases, and the COVID-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
title_sort innate immune response, microenvironment proteinases, and the covid-19 pandemic: pathophysiologic mechanisms and emerging therapeutic targets
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8931295/
https://www.ncbi.nlm.nih.gov/pubmed/35316977
http://dx.doi.org/10.1016/j.kisu.2021.12.001
work_keys_str_mv AT hollenbergmorleyd theinnateimmuneresponsemicroenvironmentproteinasesandthecovid19pandemicpathophysiologicmechanismsandemergingtherapeutictargets
AT epsteinmurray theinnateimmuneresponsemicroenvironmentproteinasesandthecovid19pandemicpathophysiologicmechanismsandemergingtherapeutictargets
AT hollenbergmorleyd innateimmuneresponsemicroenvironmentproteinasesandthecovid19pandemicpathophysiologicmechanismsandemergingtherapeutictargets
AT epsteinmurray innateimmuneresponsemicroenvironmentproteinasesandthecovid19pandemicpathophysiologicmechanismsandemergingtherapeutictargets